for-targeted-cancer-therapy Downloads
18 downloads found
Background: The cytoskeleton is composed of microfilaments, intermediate filaments, and microtubules. β-tubulin, together with α-tubulin, forms heterodimers that serve as the building blocks for microtubules. The structure of microtubules is dynamically regulated in processes related to cell movement, cytoplasmic transport, and chromosome alignment during meiosis/mitosis. ...
We are a world leader in particle accelerator technology. We design, produce and market innovative solutions for the diagnosis and treatment of cancer and other serious illnesses, and for industrial applications such as the sterilization of medical devices. Around the world, thousands of hospitals use particle accelerators and dosimetry equipment designed, produced, maintained and upgraded by ...
ByIBA
Cervical cancer is one of the most common cancers in women. Conventional treatment approaches have limitations such as serious side effects and toxicities. Currently, tumor-targeted delivery of anticancer drugs represents one of the most appropriate options to achieve optimal outcomes from the treatment and improve the quality of ...
Next-generation sequencing (NGS) has the potential to revolutionize the diagnosis and treatment of cancers and rare diseases but creates extremely large, complex, and noisy datasets for analysis. Without the right analytical technology, pinpointing causative variants and obtaining actionable insights from NGS data requires specialist skills, multiple resources, and considerable time. The ...
Bionix TruGuard is an easy-to-use, customizable tongue and jaw positioning aid that provides stability and protection in the treatment of head and neck cancers. TruGuard also removes the issues caused by pitching even if there is patient weight ...
Dophi™ N3000 Electroporation System is designed for tumor ablation with advanced precision, safety and reliability. Powered by Irreversible Electroporation (IRE) technology, Dophi™ N3000 can ablate tumors in complex anatomical environment. “IRE is a promising method for treatment of tumors near blood vessels, nerves, bile ducts, and connective tissues as these structures remains ...
We offer a variety of lock solutions that meet the individual needs of different patients. NutriLock™ has proven especially suitable in the context of cancer treatment and parenteral nutrition. Thanks to the antimicrobial agent taurolidine, it protects patients from catheter-related complications. ...
LIXTE BIOTECHNOLOGY HOLDINGS, INC. is a clinical-stage drug discovery company using biomarker technology to identify enzyme targets associated with cancer to design novel compounds to attack those ...
Cancertrack is an advanced non-invasive blood test which provides real time intel on the status of a malignancy from a safe, simple and quick blood draw. Cancertrack profiles molecular features in circulating tumor DNA and circulating tumor RNA and also evaluates ‘Circulating Tumor Cells’ (CTCs). ...
An industry pioneer and leader, Theragenics has an unparalleled history of more than 35 years in the manufacture and global supply and distribution of low-dose rate (LDR) brachytherapy seeds for the treatment of prostate cancer, intra-ocular malignancies, and other tumor types with ...
Focusing initially on breast cancer, BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to enhancing the lives of people with cancer with limited therapy options by developing novel immunotherapies to fight cancer. Immunotherapies have become the forefront of the cancer treatments because they use the body’s immune system to destroy cancer cells, offer the potential ...
Oncodeep® is a comprehensive biomarker test designed to guide treatment of advanced, metastatic solid tumors. When your patients are diagnosed with a rare cancer type or an aggressive cancer, when chemotherapy doesn't work or when cancer comes back, OncoDEEP® can provide you with clear clinical guidance. Starting from a small sample of tumor tissue, our biomarker test is able to pinpoint ...
Circulating tumor cells (CTCs) and cancer-associated macrophage-like cells (CAMLs) provide a minimally invasive alternative to tissue biopsy to determine cancer therapy and monitor treatment response and recurrence [Adams, et al., PNAS 2014; Adams, et al., Cytometry 2014]. Cancer associated cells collected on CellSieveTM microfilters are applicable for companion diagnostics and drug development. ...
Xoft offers patients and physicians a non-invasive alternative to surgery for non-melanoma skin cancer (NMSC) treatment. With the XoftAxxentElectronic Brachytherapy (eBx) System, painless, scar-free treatment of NMSC is possible with skin eBx, a form of high dose rate, low energy radiation therapy. The Axxent SPX controller is a key component of the skin eBx platform ...
The visibility you need. The support you can trust. The postoperative assessment and adjuvant radiation therapy during tumor treatment are no longer limited by metallic implants. The icotec Anterior Cervical Plate System made of BlackArmor® Carbon/PEEK offers translucency, strong and stable fixation that withstands the mechanical demands and stresses of anterior cervical stabilization. ...
OncoPeptTUME — A novel in-silico approach to model the tumor microenvironment and predict treatment efficacy and long-term survival benefits for immunotherapy applications. Cancer immunotherapy is now established as a major therapeutic modality. Cancer immunotherapy drugs elicit their anti-tumor immune response in a subset of the treated patients by activating CD8 T-cells and provide ...
Xoft offers patients and physicians a simplified alternative to traditional six-week radiation therapy for early-stage breast cancer treatment. With the Xoft Axxent Electronic Brachytherapy (eBx) System, delivery of radiation therapy in the operating room at the time of surgery is possible with intraoperative radiation therapy ...
